Close Menu

Ohio State

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.

In Cell this week: DNA-based survey of marine virus genomes,  single-cell atlas of tumor proteomic profiles, and more.

Suit for Chair

According to Retraction Watch, Ohio State University's Carlo Croce is suing to be reinstated as department chair.

Ohio State University researchers found that a phosphorothioate-modified DNA-crRNA duplex completely blocked the function of Cas12a.

A brief recap of Genetics/Genomics news the week of Dec 14, 2018: AstraZeneca, NeoGenomics, Fluidigm, Luminex, Petco Foundation, and SQI Diagnostics

Croce Out as Chair

Retraction Watch reports Ohio State has pushed Carlo Croce to step down as department chair.

Mostly Dismissed

Retraction Watch reports that a judge dismissed most of the lawsuit Ohio State University's Carlo Croce brought against the New York Times.

Patients whose tumors had methylated MGMT promoters were more likely to survive than those that did not after combination treatment with radiotherapy and temozolomide.

Science reports that Ohio State University cancer researcher Ching-Shih Chen resigned due to misconduct findings.

Prospective panel sequencing on colorectal cancer patients picked up Lynch syndrome with sensitivity and specificity that met or exceeded gene-by-gene tests.

Pages

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.